Impact of Multidrug Resistance on Experimental Empyema by Pseudomonas aeruginosa

Publisher： Karger

E-ISSN： 1423-0356|82|1|46-53

ISSN： 0025-7931

Source： Respiration, Vol.82, Iss.1, 2011-04, pp. : 46-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Multidrug‐Resistant Pseudomonas aeruginosa Using Extended‐Infusion Antimicrobial Regimens

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 1, 2015-01 ,pp. : 54-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

‘Break-point Checkerboard Plate' for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa

By Tateda Kazuhiro   Ishii Yoshikazu   Matsumoto Tetsuya   Yamaguchi Keizo  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 4, 2006-04 ,pp. : 268-272

Informa Healthcare

Access to resources Recommend Favorite

In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa

By                  

International Journal of Molecular Medicine, Vol. 30, Iss. 3, 2012-01 ,pp. : 455-464

Spandidos Publications

Access to resources Recommend Favorite

Multidrug‐resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin‐resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 19, Iss. 6, 2017-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Membrane‐active peptide PV3 efficiently eradicates multidrug‐resistant Pseudomonas aeruginosa in a mouse model of burn infection

By  

APMIS (ELECTRONIC), Vol. 126, Iss. 2, 2018-02 ,pp. : 114-122

John Wiley & Sons Inc

Access to resources Recommend Favorite